Tagged paclitaxel

Consumer Safety Watch Warns Paclitaxel Weekly More Effective, Has Fewer Side Effects Than Docetaxel for Women Diagnosed With Breast Cancer That Had Spread to the Lymph Nodes
Press Release

Consumer Safety Watch Warns Paclitaxel Weekly More Effective, Has Fewer Side Effects Than Docetaxel for Women Diagnosed With Breast Cancer That Had Spread to the Lymph Nodes

 In this study of 5,000 women, more women who received Paclitaxel once a week were likely to be alive and free of breast cancer five years after being diagnosed compared to women who received Paclitaxel every three weeks OR women who received Docetaxel (either weekly or every three weeks). Read More
Press Release

New Study Spotlights Potential of Virus To Treat Certain Lung Cancer Patients

 A new study reports that reovirus has the potential to treat certain lung cancer patients, when the reovirus is combined with two other substances known as paclitaxel and carboplatin. Read More
Press Release

Oncolytics Biotech® Inc. Announces Start of Enrollment in Randomized Phase II Ovarian Cancer Study

 The study is a randomized Phase II trial of weekly paclitaxel versus weekly paclitaxel with REOLYSIN in patients with persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer. Read More
Press Release

Apex Drugs & Intermediates Limited announces the launch of their Business Catalog

 Apex Drugs & Intermediates Limited, hyderabad is pleased to announce the launch of its newly designed official website Read More